^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
MEBGEN™ BRAF Kit

Type:
Other Approval
Related tests:

Details

Evidence
MEBGEN™ BRAF Kit was developed as a companion diagnostic for multiple anti-cancer agents in melanoma. The MEBGEN BRAF Kit is expected to be an important clinical diagnostic in guiding personalized medicine for patients with melanoma. Used for the detection of BRAF gene mutations (V600E or V600K) in DNA extracted from cancer tissue.
Cancer:
Melanoma
Gene:
BRAF (B-raf proto-oncogene)
Drug:
Braftovi (encorafenib), Mekinist (trametinib), Mektovi (binimetinib), Tafinlar (dabrafenib)
Method:
PCR